Pathophysiology of Potassium-competitive Acid Blocker-refractory Gastroesophageal Reflux and the Potential of Potassium-competitive Acid Blocker Test

about

Pathophysiology of Potassium-competitive Acid Blocker-refractory Gastroesophageal Reflux and the Potential of Potassium-competitive Acid Blocker Test

Item

http://www.wikidata.org/entity/Q57819648

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Pathophysiology of Potassium-c ...... -competitive Acid Blocker Test

@en

Pathophysiology of Potassium-c ...... -competitive Acid Blocker Test

@nl

type

Item

label

Pathophysiology of Potassium-c ...... -competitive Acid Blocker Test

@en

Pathophysiology of Potassium-c ...... -competitive Acid Blocker Test

@nl

prefLabel

Pathophysiology of Potassium-c ...... -competitive Acid Blocker Test

@en

Pathophysiology of Potassium-c ...... -competitive Acid Blocker Test

@nl

P1476

Pathophysiology of Potassium-c ...... -competitive Acid Blocker Test

@en

P2093

Hidekazu Suzuki

http://www.w3.org/2001/XMLSchema#string

Hiroya Takeuchi

http://www.w3.org/2001/XMLSchema#string

Hisako Kameyama

http://www.w3.org/2001/XMLSchema#string

Takanori Kanai

http://www.w3.org/2001/XMLSchema#string

Tatsuhiro Masaoka

http://www.w3.org/2001/XMLSchema#string

Tsuyoshi Yamane

http://www.w3.org/2001/XMLSchema#string

Yuko Kitagawa

http://www.w3.org/2001/XMLSchema#string

Yuta Yamamoto

http://www.w3.org/2001/XMLSchema#string

P2860

Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification

Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.

Validation of the GerdQ questionnaire for the management of gastro-oesophageal reflux disease in Japan

Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review

Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics.

Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study

Epidemiology and clinical characteristics of GERD in the Japanese population.

Chicago classification criteria of esophageal motility disorders defined in high resolution esophageal pressure topography.

New and future drug development for gastroesophageal reflux disease.

The Role of the Acid Pocket in Gastroesophageal Reflux Disease.

P304

577-583

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5056/JNM18036

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30347936

http://www.w3.org/2001/XMLSchema#string

P921

pathophysiology

gastroenterology

P932

6175552

http://www.w3.org/2001/XMLSchema#string